

Fundamental dimension Equity attribute | AFRMLeader $70.57▼-2.53% Cap $20.95BP/E 12.4x QuantScore65/100 | ALLYPeer $39.06▼-0.64% Cap $11.88BP/E 8.8x QuantScore44/100 | BFHPeer $99.89▼-2.50% Cap $3.84BP/E 7.7x QuantScore59/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
45/100 |
59/100 |
77/100 |
Valuation Multiples, PEG & DCF upside | 67/100 | 74/100 | 89/100 |
Health Piotroski, Altman Z, leverage & liquidity | 32/100 | 23/100 | 31/100 |
Growth Revenue / earnings growth & margins | 91/100 | 25/100 | 41/100 |
Sentiment Analyst ratings, targets & revisions | 88/100 | 39/100 | 57/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 12.4x | 8.8x | 7.7x |
Forward P/E (next FY) | 35.5x | 7.8x | 7.7x |
EV / EBITDA (TTM) | 22.7x | 9.6x | 4.0x |
Price / Sales | 5.0x | 0.7x | 0.8x |
Price / Free Cash Flow | 21.1x | -19.5x | 1.8x |
PEG ratio | 0.00 | 0.05 | 0.26 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 8 / 9 | 8 / 9 |
Altman Z-Score | 1.84 (Grey) | -0.62 (Distress) | -0.04 (Distress) |
Total debt / equity | 1.79 | 1.67 | 0.91 |
Quick ratio | 12.7x | 0.2x | 0.3x |
Interest coverage | 1.4x | 0.3x | 0.9x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +22.5% | -25.7% | -2.1% |
Net income growth YoY | +3597.9% | +27.5% | +87.0% |
Gross margin (TTM) | 68.1% | 49.8% | 64.0% |
Operating margin (FY) | 22.1% | 8.6% | 13.1% |
FCF margin (FY) | 25.1% | -5.3% | 44.5% |
5. Trailing price performancePrice change over period |
1M return | -2.1% | +0.8% | -1.6% |
3M return | -0.2% | -9.0% | -4.2% |
6M return | +10.0% | -11.6% | +15.9% |
Year to date | -5.8% | -13.8% | +34.9% |
1Y return | -7.0% | -6.6% | +52.5% |
3Y return | +258.3% | +71.6% | +251.5% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-94.94 -234.5% premium | $-98.69 -352.7% premium | $89.92 -10.0% premium |
Wall Street consensus target | $95.79 +35.7% · range $75.00–$115.00 | $47.44 +21.5% · range $40.00–$56.00 | $116.58 +16.7% · range $104.00–$132.00 |
Consensus stance | 74% Buy26% Hold0% Sell | 63% Buy34% Hold3% Sell | 41% Buy57% Hold3% Sell |